Determination of treatment modalities for diabetic retinopathy and diabetic maculopathy -Strategic approach using molecular and cellular biological methods-
Determination of treatment modalities for diabetic retinopathy and diabetic maculopathy -Strategic approach using molecular and cellular biological methods-
批准号:
15591841
负责人:
YAMASHITA Hidetoshi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Various factors are involved in the pathogenesis of diabetic retinopathy and diabetic maculopathy (macular edema). The candidates of the risk factors are factors related to oxidative stress and retinal angiogenesis. As the first step, to investigate the candidate molecules to play important roles in diabetic retinopathy, the expression levels of the bio-marker of cell damage due to oxidative stress ((8-OHdG and NOx) and cytokines (VEGF and IL-6) were measured in the vitreous humor obtained from the diabetic eyes after securing the written permission. This study was approved by the ethical committee of Yamagata University Faculty of Medicine. This study has revealed that the diabetic retinopathy and the diabetic maculopathy are closely related to the oxidative stress and VEGF, IL-6. As the second step, to investigate the molecular pathogenesis of diabetic retinopathy by focusing the retinal damage to retinal neurons, the intracellular signal transduction of hyperglycemia, including abno … More rmal metabolic pathways and cytokine expression acceleration, has been investigated using the in vitro systems. This study has revealed that diacylglycerol activates protein kinase C, which increases VEGF expression in retinal cells.Taken together, VEGF is one of the main factors to be involved in the pathogenesis of diabetic retinopathy and maculopathy. One of the single nucleotide polymorphisms (SNPs) in the VEGF gene was investigated. The frequencies of VEGF +813 C-T (CC, CT, TT) were determined in DNA from 108 subjects (non DM=12 subjects, DM=96 subjects). The frequencies of the VEGF +813 C_T polymorphisms were similar in both DM and non DM groups. The severity of retinopathy was not related to VEGF +813 polymorphism. The results of this study have revealed that the expression levels of cytokines and oxidative stress related factors, not the genetic factor were related to diabetic retinopathy and maculopathy. It is mandatory to search for the more useful factors relevant to diabetic retinopathy and maculopathy to set up the system to determine the treatment modalities for diabetic retinopathy and maculopathy. Less
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
糖尿病網膜症の疫学
糖尿病视网膜病变的流行病学
DOI:
--
发表时间:
2016
期刊:
あたらしい眼科
影响因子:
--
作者:
[堀中真野, 吉田達士, 曽和義広, 酒井敏行, 佐々木真理子]
通讯作者:
佐々木真理子
「眼の自己免疫疾患」サイトカインと眼。
“眼睛自身免疫性疾病”细胞因子和眼睛。
DOI:
--
发表时间:
2003
期刊:
影响因子:
--
作者:
[寺島和人, 山下英俊]
通讯作者:
山下英俊
寺島和人, 山下英俊: "眼の自己免疫疾患"サイトカインと眼(分担). 35-43 (2003)
Kazuto Terashima、Hidetoshi Yamashita:“眼睛的自身免疫性疾病”细胞因子和眼睛(共享)35-43(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
知っておくべき高血圧の知識(2004-2005)
关于高血压你需要了解什么(2004-2005)
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[神尾聡美, 山下英俊]
通讯作者:
山下英俊
網膜血管新生とサイトカイン
视网膜新生血管和细胞因子
DOI:
--
发表时间:
2004
期刊:
Angiotensin Research 1
影响因子:
--
作者:
[佐藤さくら, 佐藤浩章, 川崎良, 山下英俊]
通讯作者:
山下英俊
共 25 条
Comprehensive Social Scientific Study on Radioactive Waste Disposal Issues
-
批准号:19H04335
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.4万
-
财政年份:2019
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular epidemiological study on choroidopathy in diabetic eyes
-
批准号:18K09439
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2018
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular mechanisms of progression of diabetic retinopathy focusing inflammatory mechanisms by dendritic cells in vitreous
-
批准号:15K10832
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Research on policies for the promotion of locally initiated renewable energy projects
-
批准号:25281068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2013
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular pathogenesis and strategic approach of treatment for diabetic retinopathy
-
批准号:24592617
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
New strategy to treat diabetic retinopathy using stabilization of hyalocyte-vasucular endothelial cell correlation
-
批准号:21592215
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
An analysis of the effects of the waste tax on the reduction of the final disposal of industrial wastes
-
批准号:20710036
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Changes of retinal vascular structure in diabetic retinopathy andstrategy of treatment
-
批准号:19592004
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular Mechanisms of Damage to Retinal Neuronal Cells in Diabetic Retinopathy and New Therapeutic Modalities
-
批准号:17591819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Mutation analysis of tumors in ophthalmological area to to choose the treatment modalities---mutation analysis using paraffin specimens---
-
批准号:13671819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of therapeutic agents and gene therapy by inhibiting new vessel formation
-
批准号:11671724
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
MOLECULAR MECHANISMS OF CORNEAL WOUND HEALING AFTER PHOTO-REFRACTIVE CORNEAL SURGERY
-
批准号:11557127
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular mechanisms of ocular angiogenesis and development of therpeutic agents
-
批准号:09557136
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:1997
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular biology of retinal development and retinal degeneration
-
批准号:09671787
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of New Immunotherapy in Ophthalmology
-
批准号:60440079
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$21.18万
-
财政年份:1985
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位:
养精通络方调控HIF-1α/VEGF信号通路调控“氧化应激-线粒体自噬”促进薄型子宫内膜修复的机制研究
-
批准号:2026JJ82186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾晶
-
依托单位: